supplementation due to insufficient maternal supply is needed to prevent dehydration and severe hyperbilirubinemia. DHM retains some of the anti-infective components found in mother's own milk and may support a healthier gut microbiome than infant formula (Parra-Llorca et al., 2018; Underwood et al., 2015) . Researchers conducting qualitative studies also have shown that some mothers find it to be a more natural option and a more comfortable way to supplement their infant while establishing their mature milk supply (Kair & Flaherman, 2017; Rabinowitz et al., 2018) .
The Joint Commission is an independent, nonprofit organization that accredits and certifies health care organizations and programs in the United States as meeting quality care performance standards, including those pertaining to breastfeeding. Beginning in January 2014, hospitals with greater than 1,100 births annually in the United States were required to submit data about the Joint Commission Perinatal Care Measure Set, which includes breastfeeding. The Joint Commission (2013) included DHM in its definition of "exclusive breastmilk feeding," so hospitals seeking to improve on this quality metric can improve their rates by replacing formula with DHM. Hospitals using DHM for healthy newborns have reported higher exclusive breastfeeding at discharge compared to those that do not use DHM . The use of DHM is increasing in newborn nurseries and neonatal intensive care units (NICUs), but usage varies geographically, is inconsistent, and may be limited by lack of knowledge among health care providers (HCPs; Belfort et al., 2018; Colaizy, 2015; Hagadorn et al., 2016; Parker et al., 2013; Perrine & Scanlon, 2013; Sen et al., 2018) . Reported maternal barriers to DHM utilization include unfamiliarity, cost, and access issues (Kair & Flaherman, 2017; Rabinowitz et al., 2018) . Racial and socioeconomic disparities associated with formula supplementation of breastfed babies during the birth hospitalization have been described (Nguyen et al., 2017) . Additionally, racial disparities have been shown for infants cared for in the NICU (Brownell et al., 2014 ; however, maternal factors associated with DHM supplementation of healthy, term and late-preterm infants during birth hospitalization have not been described.
The aim of this exploratory study was to investigate the maternal factors associated with DHM versus formula supplementation in the postpartum/well newborn care unit, with a particular focus on maternal demographic characteristics thought to be associated with other (not specific to DHM) maternal and neonatal health care disparities. We hypothesized that DHM use in this population would be independently associated with maternal race, as has been previously described in studies in the NICU setting.
Methods

Design
A retrospective cohort study was designed to answer our research aim. This design was used to investigate relationships between maternal demographic and clinical characteristics and the outcome of DHM versus formula supplementation in infants. This study was approved for full waiver of consent by the institutional review board of the University of Iowa.
Setting
This institution is home to one of the oldest Human Milk Banking Association of North America milk banks in the United States and has allowed DHM use for supplementation of breastfed infants in the well newborn unit since 2006 (Kair et al., 2014) . DHM is the first-line supplementation option recommended in the well newborn unit when supplemental feedings are medically indicated. DHM is available for inpatient newborns by physician order, and the cost is covered by the inpatient unit as part of the food and nutrition budget but not reimbursed by insurance. Medical indications for supplementation are at the discretion of the prescribing physician. Parents have the ultimate choice and make the decision whether their child receives donor human milk or formula after reviewing risks and benefits and any questions they have with the provider. International Board Certified Lactation Consultants work every day of the week at this hospital, and they see all postpartum women unless postpartum women decline lactation services. Women who receive prenatal care at this institution are offered a prenatal breastfeeding class as well.
Sample
All infants included in this study were born at a single midwestern medical center where a total of 1,712 live births occurred in 2014. All infants in this study were clinically stable and had clinically stable mothers, were born following at least 35 weeks gestation, and weighed at least 1,750 grams at birth. This is the population that receives mother-baby,
Key Messages
• • Donor human milk use is on the rise in the well newborn setting, and researchers have not explored maternal characteristics associated with its use. • • In this retrospective cohort study of breastfed infants who were supplemented during the birth hospitalization, nonwhite, non-English-speaking, and publicly insured women were less likely to supplement with donor human milk than with formula. • • The goal of improving public health through breastfeeding promotion may be inhibited by not targeting donor human milk programs to these groups. Identifying the drivers of these disparities is necessary to inform patient-centered interventions that address the needs of women with diverse backgrounds.
rooming-in care at the study site medical center; infants born prior to 35 weeks or lower than 1,750 grams at birth are admitted directly to the NICU. Mother-infant dyads were included in this study if the mother breastfed and used either formula or DHM for supplementation during the birth hospitalization. We excluded infants admitted to or transferred to or from the NICU, seeking to study supplementation practices specifically among otherwise healthy, term and latepreterm newborns. The study sample size of breastfed newborns who supplemented with donor milk or formula but not both, resulted from of reviewing 1 year's worth of newborn deliveries. A total 678 infants met our inclusion criteria, of whom 372 (55%) supplemented with formula and 306 (45%) supplemented with DHM, which we anticipated would provide adequate power to detect a difference in DHM versus formula use by race.
Measurement
Data collection instruments to collect clinical and demographic data systematically from infant and maternal charts were created for this study using REDcap ( 
Data Collection
The study was conceptualized in 2014. Data were collected between 2015 and 2018 on all infants admitted to the well newborn/postpartum care unit at our hospital from January through December 2014. All deidentified data, including maternal demographic characteristics and supplement method, were manually extracted from infant and maternal electronic medical records by researchers who had been oriented to the records and data collection procedures; data were entered in a secure REDcap (Harris et al., 2019) electronic database.
Data Analysis
Raw data were categorized for analysis. We restricted our data set for this analysis to only those infants who were breastfed and supplemented with either DHM or formula but not both. Chi-square and Fisher's exact tests were used to examine differences in maternal characteristics of participants who used DHM versus formula supplementation.
Bivariate logistic regression was used to examine the association between supplement choice and maternal race-ethnicity. Finally, we examined this association in a logistic regression model adjusted for gestational age of the infant and the following maternal characteristics: maternal insurance, primary language, maternal age at delivery, mode of delivery, and parity. Twenty-five had missing data for raceethnicity, leaving 653 in the sample for the logistic regression. All analyses were conducted in SAS 9.4.
Results
Using Pearson's chi-square and Fisher's exact tests we found that all explored maternal characteristic variables of women who used DHM compared to formula supplementation differed significantly (Table 1) . When examining the association of supplement choice and maternal race-ethnicity in the unadjusted analysis, we found non-Hispanic black women were the least likely to use DHM, followed by Hispanic women, Asian women, and women who reported "other" race. After adjusting for maternal characteristics, the disparity between supplement choice and race-ethnicity remained; the largest disparity was observed for Hispanic women, as they were 72% less likely to use DHM than non-Hispanic white women. In the adjusted model, non-Hispanic black, Asian, and "other" women were also less likely to use DHM than non-Hispanic white women (Table 2) . Additional demographic characteristics associated with supplement choice included primary language and insurance type. We found women who were publicly insured and non-English speaking were less likely to use DHM. Clinical characteristics associated with supplement choice were parity, delivery mode, and gestational age of the newborn (Table 2) . Post hoc, we restricted the analytic sample to only those infants born at term (37 or more weeks gestation), and findings were similar (data not shown).
Discussion
Disparities in who uses a given hospital intervention, in this case, DHM rather than formula, can come from issues with the system, the HCP working within systems, or the patients. The Institute of Medicine (2002) defines health care disparities as "differences in the quality of care received by minorities and non-minorities who have equal access to care-that is, when these groups have similar health insurance and the same access to a doctor-and when there are no differences between these groups in their preferences and needs for treatment. Therefore, barring patient preference, use of DHM in the participants in our sample at our single site would represent a health care disparity. Systems may not provide resources that specifically support the needs of particular groups of patients. HCP may discuss DHM differently with patients from different backgrounds. Implicit bias may contribute, leading providers to not offer patients an intervention in which they assume the patients will not be interested.
In an example of how system and HCP factors may interact, in our study, information about DHM was available in both English and Spanish; however, the retrospective nature of this study precluded us from determining whether HCPs spoke the patients' native languages and whether interpreters were used when discussing DHM and formula as supplementation options. The participants from different racial, ethnic, or socioeconomic backgrounds may have had different personal and family experiences with formula supplementation. It is possible that the same factors driving the racial-ethnic and socioeconomic disparity of increased formula supplementation in breastfed infants (Nguyen et al., 2017) were not mitigated by making DHM available. For example, researchers have reported women viewed DHM as "gross" (Kair & Flaherman, 2017; Rabinowitz et al., 2018) , and it is possible that familiarity with and acceptability of DHM as a supplementation option varied across racial, ethnic, or socioeconomic backgrounds.
With respect to our finding that mothers with public insurance were less likely to give DHM than those with private insurance, one potential reason for this difference may be differences in ongoing insurance coverage of DHM for outpatient use. During the newborn hospitalization at our facility, the hospital unit covers the cost of DHM, but after discharge, ongoing DHM supplementation is billed to insurers or patients directly. Therefore participants with public insurance may not have had access to DHM after discharge, as only some private-pay insurers (but not public insurers) in the state where the study occurred cover ongoing donor milk supplementation (Kair et al., 2014) . Kair and Flaherman (2017) conducted a qualitative study exploring DHM and formula supplementation in the well newborn population at Fisher's exact test used when cell sizes fewer than 5. b "Other" is defined as nonmissing data responses other than the other categories for that variable.
our hospital. They found the lack of access to DHM for ongoing supplementation was a barrier for some participants to its use during the newborn hospitalization, despite the cost being covered while hospitalized. Our findings, if replicated in other settings, have implications for the health of infants in addition to their significance for health care utilization. Differential increased use of pasteurized DHM for white infants and those from higher socioeconomic backgrounds may widen health disparities in a number of ways. If DHM supplementation rather than formula leads mothers to resuming exclusive breastfeeding and to breastfeed for a longer duration or it has direct benefits on infant health, as has been seen in preterm infants (Dritsakou et al., 2016; Mannel & Peck, 2018) , then nonwhite infants and/or those with public insurance who are less likely to use DHM than formula are receiving these benefits at lower rates than white mothers and/or those with private insurance. If there are no direct benefits to healthy, term mother-infant dyads from DHM supplementation (Kair et al., 2019) , then the money spent on these programs has opportunity costs that must be considered. DHM from the Mother's Milk Bank of Iowa cost $15 for 100 mL at the time the data for this study were collected and was costing $1,000 to $2,000 per month in the well newborn unit's nutrition budget annually.
Our study was exploratory; therefore, our findings highlight the need for future prospective research to determine whether and to what extent health care disparities and/or patient preferences relatively contribute to the disproportionate lower use of DHM by mothers of other race-ethnicity when compared to non-Hispanic white mothers. Researchers need to examine the differences in infant health outcomes from DHM versus formula supplementation to help determine the prudence of working toward increasing uptake among families from diverse backgrounds versus deimplementation of DHM in well newborn/postpartum care units. If DHM is not found to have appreciable benefits for this population over infant formula, then money currently being spent on DHM in well newborn/postpartum units could be reallocated toward other, evidence-based interventions to support breastfeeding motherinfant dyads from diverse backgrounds.
Limitations
Our study must be placed in the context of various factors. This was a retrospective study using data from infants in one hospital in the midwestern United States, and the results cannot be generalizable to other hospitals within the United States or globally. The data for this study were collected from the electronic medical record, and it is unclear from the available retrospective data whether parents were offered donor milk and declined it or if they were not offered it. We were limited by the maternal racial-ethnic and primary-language categories listed in the birth mother's medical record and did not have data on race or language for the infant's father, other parent, or caregiver. We collected data from 1 year only, so the study sample is relatively low at 678. We did not collect data regarding multiple births, so it is possible in some cases that twins were both included in the analysis. We also do not know mothers' exclusive breastfeeding intention; we attempted to collect these data, but they were not reliably recorded in the electronic medical record. It is, therefore, very likely that at least some of the participants who supplemented with formula did so because they intended to feed their baby both their own milk and formula. We also do not have data on indications for supplementation or the lactation support individual mothers received.
Conclusion
Implementation of a DHM program in the well newborn setting that is not specifically targeted to mothers of color, those who do not speak English, and those with public insurance has the potential to widen health disparities despite the goal of improving public health through breastfeeding promotion. Further research is necessary to determine the underlying reasons for these disparities and, from that, to provide focused, person-centered intervention to address the needs of lowincome women, non-English speakers, and mothers of color.
